Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Tuesday, April 22, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Tags
Imfinzi
Tag:
Imfinzi
Latest Pharma-News
AZ’s Lynparza and Imfinzi combination shows positive results in advanced ovarian cancer
admin
-
April 6, 2023
0
Latest Pharma-News
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
admin
-
March 30, 2023
0
Latest Pharma-News
Imfinzi significantly improved event-free survival in AEGEAN Phase III trial for patients with resectable nSCLC
admin
-
March 9, 2023
0
Latest Pharma-News
Imfinzi plus chemotherapy approved in EU for patients with advanced biliary tract cancer
admin
-
December 21, 2022
0
Latest Pharma-News
Imfinzi plus chemotherapy improved survival benefit in advanced biliary tract cancer
admin
-
September 12, 2022
0
Latest Pharma-News
Imfinzi plus chemotherapy granted Priority Review in for biliary tract cancer
admin
-
May 4, 2022
0
Latest Pharma-News
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment
admin
-
January 16, 2022
0
Latest Pharma-News
AZ’s Imfinzi approved in China for extensive-stage small cell lung cancer
admin
-
July 19, 2021
0
Latest Pharma-News
AZ’s Imfinzi approved in the US for less-frequent, fixed-dose use
admin
-
November 22, 2020
0
Latest Pharma-News
Imfinzi approved in the EU for the treatment of lung cancer
admin
-
September 2, 2020
0
Latest Pharma-News
Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use
admin
-
August 18, 2020
0
Latest Pharma-News
AstraZeneca’s Imfinzi and tremelimumab granted Orphan Drug Designation in the US for the treatment of hepatocellular carcinoma
admin
-
January 21, 2020
0
1
2
Page 1 of 2
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025